非布索坦
高尿酸血症
别嘌呤醇
痛风
医学
尿酸
内科学
不利影响
泌尿科
药理学
出处
期刊:PubMed
日期:2018-07-01
卷期号:31 (4(Special)): 1623-1627
被引量:1
摘要
The aim of this research work was to observe and analyze the efficacy of febuxostat and allopurinol in the treatment of gout with hyperuricemia. The 160 patients who has been diagnosed with gout and hyperuricemia in our hospital were selected as research objects. They were randomly divided into research group and control group, each containing 80. The control group received conventional allopurinol treatment, while the research group was treated with febuxostat. Then, the treatment efficacy was compared between the two groups. Through comparison of blood uric acid levels between the two groups after treatment, it can be known that improvement was more significant in the research group, P<0.05. The adverse reaction rate in the research group was significantly lower, P<0.05. For patients with gout and hyperuricemia, febuxostat therapy has better efficacy than that of allopurinol.
科研通智能强力驱动
Strongly Powered by AbleSci AI